SKI Market

Indian Indices

Nifty

25,758.00 -81.65
(-0.32%)

Sensex

84,742.65 351.38
( 0.42%)

Bank Nifty

58,960.40 -261.95
( -0.44%)

Nifty IT

37,789.90 -340.70
( -0.89%)

Global Indices

Nasdaq

48,074.52 493.22
(1.04%)

Dow Jones

6,906.36 44.85
(0.65%)

Hang Seng

50,166.54 -436.26
(-0.86%)

Nikkei 225

9,661.39 19.38
(0.20%)

Forex

USD-INR

89.93 -0.16
(-0.18%)

EUR-INR

104.64 -0.26
(-0.25%)

GBP-INR

119.76 -0.28
(-0.23%)

JPY-INR

0.58 0.00
(-0.73%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Glenmark Pharmaceuticals Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

532296

INE935A01035

848.3143291

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

GLENMARK

37.45

55111

EPS(TTM)

Face Value()

Div & Yield %

52.14

0.13

Back

SRF standalone net profit rises 61.10% in the September 2025 quarter

Oct 27,2025

Net profit of SRF rose 61.10% to Rs 362.66 crore in the quarter ended September 2025 as against Rs 225.11 crore during the previous quarter ended September 2024. Sales rose 5.18% to Rs 2751.33 crore in the quarter ended September 2025 as against Rs 2615.87 crore during the previous quarter ended September 2024.

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	2751.33	2615.87	5
OPM %	24.53	18.74	-
PBDT	652.67	461.75	41
PBT	482.56	303.36	59
NP	362.66	225.11	61

25,758.00 -81.65 (-0.32%)

84,742.65 351.38 ( 0.42%)

58,960.40 -261.95 ( -0.44%)

37,789.90 -340.70 ( -0.89%)

48,074.52 493.22 (1.04%)

6,906.36 44.85 (0.65%)

50,166.54 -436.26 (-0.86%)

9,661.39 19.38 (0.20%)

89.93 -0.16 (-0.18%)

104.64 -0.26 (-0.25%)

119.76 -0.28 (-0.23%)

0.58 0.00 (-0.73%)